About 240,000 results
Open links in new tab
  1. Dean Tang, PhD - Roswell Park Comprehensive Cancer Center

    Dean Tang, PhD, is currently Distinguished Professor and Chair of Department of Pharmacology & Therapeutics at the Roswell Park Comprehensive Cancer Center in Buffalo, NY. He also …

  2. Cancer Heterogeneity and Plasticity-Editorial Board

    Dean Tang, PhD, is currently Distinguished Professor and Chair of Department of Pharmacology & Therapeutics at the Roswell Park Comprehensive Cancer Center in Buffalo, NY. He also …

  3. Loop | Dean G Tang

    Dean Tang, Ph.D, is currently Professor and Chair of Department of Pharmacology & Therapeutics at the Roswell Park Comprehensive Cancer Center (RPCC) in Buffalo, NY. He …

  4. Dean G. Tang‬ - ‪Google Scholar

    ‪Roswell Park Comprehensive Cancer Center‬ - ‪‪Cited by 23,052‬‬ - ‪Stem Cells‬ - ‪Cancer Stem Cells‬ - ‪Prostate Cancer‬ - ‪Cancer Cell Heterogeneity‬

  5. Dean Tang - Professor at Roswell Park Comprehensive Cancer Center ...

    Professor at Roswell Park Comprehensive Cancer Center · Experience: Roswell Park Comprehensive Cancer Center · Location: Buffalo · 208 connections on LinkedIn. View Dean...

  6. Department of Pharmacology & Therapeutics Faculty | Roswell Park

    Department of Pharmacology & Therapeutics Faculty Primary faculty Dean Tang, PhD Distinguished Professor of Oncology Co-Leader, CCSG Developmental Therapeutics Program …

  7. Understanding and targeting prostate cancer cell heterogeneity

    Abstract Prostate cancer (PCa) is a prevalent malignancy that occurs primarily in old males. Prostate tumors in different patients manifest significant inter-patient heterogeneity with …

  8. Tang DG (0000-0001-5029-1174) - ORCID

    Jul 24, 2018 · miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells.

  9. Dean G Tang | Allied Academies Conferences | International …

    Dr. Tang obtained his PhD in Cancer Biology in 1994 and stayed at WSU for a few years to explore apoptosis-based anti-prostate cancer therapeutics.

  10. <i>Cancer Heterogeneity and Plasticity:</i> 2024 in Review

    Editor-in-Chief, Cancer Heterogeneity and Plasticity Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA